Puerarin Attenuates Osteoarthritis via Multi‐Target Regulation of Inflammation, Apoptosis, and ECM Degradation
Journal of Cellular and Molecular Medicine · 2025-09 · 29 (18)
DOI: 10.1111/jcmm.70833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 25.09.2025. Verfasst von Yanjing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan Cit…. Hauptthemen laut MEDLINE: Isoflavones, Osteoarthritis, Apoptosis, Extracellular Matrix. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoarthritis (OA) is a degenerative joint disease characterised by cartilage breakdown, leading to pain and reduced quality of life. This study aims to investigate the therapeutic potential of Puerarin (PUE), a natural compound derived from Pueraria lobata , in modulating OA progression. Employing a multifaceted approach that included bioinformatics analysis, molecular docking, in vitro assays, and in vivo experiments, we identified 57 overlapping targets between PUE and OA‐related genes, suggesting a multi‐target interaction model. Our findings revealed that PUE effectively inhibited inflammatory cytokine production and protected chondrocytes from apoptosis at non‐cytotoxic concentrations (5 and 10 μM), promoting extracellular matrix synthesis by reversing IL‐1β‐induced degradation of Aggrecan and Collagen II while reducing MMP‐13 and ADAMTS5 expression. Furthermore, PUE was shown to attenuate IL‐1β‐induced apoptosis by restoring BCL‐2 levels and decreasing cleaved caspase‐3 levels. In vivo, PUE administration in a destabilisation of the medial meniscus (DMM) mouse model significantly slowed OA progression, preserving cartilage structure and reducing osteophyte formation. Moreover, PUE activated the PI3K‐AKT signalling pathway, underscoring its anti‐inflammatory and anti‐apoptotic mechanisms. Collectively, these results support Puerarin's potential as a disease‐modifying agent in OA treatment, warranting further clinical exploration and consideration of its application in combination therapies to enhance cartilage protection and repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan City, China.
- Department of Anesthesiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
ORCID-Profile: Yanjing Zhang
Zitieren
APA
Zhang, Y., Chen, Z., Cheng, Y., Zhou, Y., Yang, Y., Che, M., Zhang, Y., & Li, Y. (2025). Puerarin Attenuates Osteoarthritis via Multi‐Target Regulation of Inflammation, Apoptosis, and ECM Degradation. Journal of Cellular and Molecular Medicine, 29(18). https://doi.org/10.1111/jcmm.70833
Vancouver
Zhang Y, Chen Z, Cheng Y, Zhou Y, Yang Y, Che M, et al. Puerarin Attenuates Osteoarthritis via Multi‐Target Regulation of Inflammation, Apoptosis, and ECM Degradation. Journal of Cellular and Molecular Medicine. 2025;29(18). doi:10.1111/jcmm.70833
BibTeX
@article{Zhang2025,
author = {Zhang, Yanjing and Chen, Zhiqiang and Cheng, Ye and Zhou, Yuxuan and Yang, Yaoheng and Che, Mengjiao and Zhang, Yiwen and Li, Yalan},
title = {Puerarin Attenuates Osteoarthritis via Multi‐Target Regulation of Inflammation, Apoptosis, and ECM Degradation},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {18},
doi = {10.1111/jcmm.70833}
}
EUVIMED